Prostatectomy surgical technique and results, Urology, 2004;64(1):148–51.
27. Nehra A, Kumar R, Ramakumar S, et al., Pharmacoangiographic evidence of the presence and anatomical dominance of accessory pudendal artery(s), J Urol, 2008;179(6):2317–20.
28. Ayyathurai R, Manoharan M, Nieder AM, et al., Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients, BJU Int, 2008;101(7):833–6.
29. Hollenbeck BK, Dunn RL, Wei JT, et al., Determinants of long- term sexual health outcome after radical prostatectomy measured by a validated instrument, J Urol, 2003;169(4):1453–7.
30. Kovanecz I, Rambhatla A, Ferrini MG, et al., Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection, BJU Int, 2008;101(2):203–10.
31. Rambhatla A, Kovanecz I, Ferrini M, et al., Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review, Int J Impot Res, 2008;20(1):30–4.
32. Schwartz EJ, Wong P, Graydon RJ, Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy, J Urol, 2004;171(2 Pt 1):771–4.
33. Hatzimouratidis K, Burnett AL, Hatzichristou D, et al., Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application, Eur Urol, 2009;55(2):334–47.
34. Lysiak JJ, Yang SK, Klausner AP, et al., Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation, J Urol, 2008;179(2):779–85.
35. Rosano GM, Aversa A, Vitale C, et al., Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk, Eur Urol, 2005;47(2):214–20.
36. Bella AJ, Deyoung LX, Al-Numi M, et al., Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications, Eur Urol, 2007;52(4):990–1005.
37. Montorsi F, Guazzoni G, Strambi LF, et al., Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial, J Urol, 1997;158(4):1408–10.
38. Mulhall J, Land S, Parker M, et al., The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function, J Sex Med, 2005;2(4):532–40.
39. Yiou R, Cunin P, de la Taille A, et al., Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy, J Sex Med, 2010;8(2):575–82.
40. Raina R, Pahlajani G, Agarwal A, et al., The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity, BJU Int, 2007;100(6):1317–21.
41. Pahlajani G, Raina R, Jones S, et al., Vacuum erection devices revisited: its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy, J Sex Med, 2010; (Epub ahead of print).
42. Zippe CD, Jhaveri FM, Klein EA, et al., Role of Viagra after radical prostatectomy, Urology, 2000;55(2):241–5.
43. Padma-Nathan H, McCullough AR, Levine LA, et al., Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy, Int J Impot Res, 2008;20(5):479–86.
44. Bannowsky A, Schulze H, van der Horst C, et al., Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil, BJU Int, 2008;103(10):1440, author reply 1440–1.
45. Montorsi F, Brock G, Lee J, et al., Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy, Eur Urol, 2008;54(4):924–31.
46. Titta M, Tavolini IM, Moro, FD et al., Sexual counseling improved erectile rehabilitation after non-nerve-sparing radical retropubic prostatectomy or cystectomy—results of a randomized prospective study, J Sex Med, 2006;3(2):267–73.
47. Ciancio SJ, Kim ED, Penile fibrotic changes after radical retropubic prostatectomy, BJU Int, 2000;85(1):101–6.
48. Dalkin BL, Christopher BA, Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device, Int J Impot Res, 2007;19(5):501–4.
49. Zippe C, Nandipati K, Agarwal A, et al., Sexual dysfunction after pelvic surgery, Int J Impot Res, 2006;18(1):1–18.
50. Raina R, Agarwal A, Ausmundson S, et al., Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function, Int J Impot Res, 2006;18(1):77–81.
51. Bosshardt RJ, Farwerk R, Sikora R, et al., Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device, Br J Urol, 1995;75(6):786–91.
52. Koeman M, van Driel MF, Schultz WC, et al., Orgasm after radical prostatectomy, Br J Urol, 1996;77(6):861–4.
53. Barnas JL, Pierpaoli S, Ladd P, et al., The prevalence and nature of orgasmic dysfunction after radical prostatectomy, BJU Int, 2005;95(3):452–3, author reply 453.
54. Salonia A, Gallina A, Briganti A, et al., Postoperative orgasmic
function increases over time in patients undergoing nerve- sparing radical prostatectomy, J Sex Med, 2010;7(1 Pt 1):149–55
55. Choi JM, Nelson CJ, Stasi J, et al., Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors, J Urol, 2007;177(6):2223–6.
56. Lee J, Hersey K, Lee CT, et al., Climacturia following radical prostatectomy: prevalence and risk factors, J Urol, 2006;176(6 Pt 1):2562–5, discussion 2565.
57. Martinez-Salamanca García JI, Jara Rascón J, Moncada Iribarren I, et al., Orgasm and its impact on quality of life after radical prostatectomy, Actas Urol Esp, 2004;28(10):756–60.
58. Hetrick DC, Ciol MA, Rothman I, et al., Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study, J Urol, 2003;170(3):828–31.
59. Nehra A, Grantmyre J, Nadel A, et al., Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy, J Urol, 2005;173(6):2067–71.
60. Barnas J, Parker M, Guhring P, et al., The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis, Eur Urol, 2005;47(3):361–5, discussion 365.
61. Messaoudi R, Menard J, Parquet H, et al., Modification of sexual desire and orgasm after radical prostatectomy for prostate cancer, Prog Urol, 2011;21(1):48–52
62. Schover LR, Fouladi RT, Warneke CL, et al., Defining sexual outcomes after treatment for localized prostate carcinoma, Cancer, 2002;95(8):1773–85.
63. Dahn JR, Penedo FJ, Gonzalez JS, et al., Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire, Urology, 2004;63(2):273-7.
64. Dalkin BL, Christopher BA, Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments, Urol Oncol, 2008;26(3):281–5.
65. Nelson CJ, Deveci S, Stasi J, et al., Sexual bother following radical prostatectomyjsm, J Sex Med, 2010;7(1 Pt 1):129–35.
66. De Nunzio C, Carluccini A, Cicione A, et al., Prostate cancer does not influence androgen levels: a radical prostatectomy cohort study, Urol Int, 2011;86(2):161–6.
67. Morales A, Schulman CC, Tostain J, et al., Testosterone Deficiency Syndrome (TDS) needs to be named appropriately – the importance of accurate terminology, Eur Urol, 2006;50(3):407–9.
68. Isbarn H, Pinthus JH, Marks LS, et al., Testosterone and prostate cancer: revisiting old paradigms, Eur Urol, 2009;56(1):48–56.
42
EUROPEAN UROLOGICAL REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68